144 related articles for article (PubMed ID: 1508581)
1. Therapeutic use of surfactant in neonatal respiratory distress syndrome. Correlation between pulmonary X-ray changes and clinical data.
Bick U; Müller-Leisse C; Tröger J; Jorch G; Roos N; Meyer zu Wendischhoff J; Flothmann U; Kachel W; Lemburg P; Linderkamp O
Pediatr Radiol; 1992; 22(3):169-73. PubMed ID: 1508581
[TBL] [Abstract][Full Text] [Related]
2. Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome.
Dinger J; Schwarze R; Rupprecht E
Pediatr Radiol; 1997 Jan; 27(1):26-31. PubMed ID: 8995163
[TBL] [Abstract][Full Text] [Related]
3. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Yost CC; Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
[TBL] [Abstract][Full Text] [Related]
4. [A multicenter study on the surfactant treatment in late-preterm or term infants with respiratory distress syndrome].
Collaborative Study Group for Late-preterm/Term Infants with Respiratory Distress
Zhonghua Er Ke Za Zhi; 2014 Oct; 52(10):724-8. PubMed ID: 25537535
[TBL] [Abstract][Full Text] [Related]
5. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
[TBL] [Abstract][Full Text] [Related]
6. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
[TBL] [Abstract][Full Text] [Related]
7. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
8. Lung ultrasonography score versus chest X-ray score to predict surfactant administration in newborns with respiratory distress syndrome.
Perri A; Riccardi R; Iannotta R; Di Molfetta DV; Arena R; Vento G; Zecca E
Pediatr Pulmonol; 2018 Sep; 53(9):1231-1236. PubMed ID: 29870158
[TBL] [Abstract][Full Text] [Related]
9. Respiratory distress syndrome treated with human surfactant: radiographic findings.
Edwards DK; Hilton SV; Merritt TA; Hallman M; Mannino F; Boynton BR
Radiology; 1985 Nov; 157(2):329-34. PubMed ID: 3840268
[TBL] [Abstract][Full Text] [Related]
10. Radiographic findings associated with surfactant treatment.
Soll RF; Horbar JD; Griscom NT; Barth RA; Lucey JF; Taeusch HW
Am J Perinatol; 1991 Mar; 8(2):114-8. PubMed ID: 2006936
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.
Soll RF; Morley CJ
Cochrane Database Syst Rev; 2001; (2):CD000510. PubMed ID: 11405966
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
Chen A; Shi LP; Zheng JY; Du LZ
Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
[TBL] [Abstract][Full Text] [Related]
13. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
[TBL] [Abstract][Full Text] [Related]
14. [X-ray findings and clinical analysis for newborn infants with neonatal respiratory distress syndrome].
Zhao ZM; Yang L; Cui B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 32(6):1069-74. PubMed ID: 18182729
[TBL] [Abstract][Full Text] [Related]
15. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
17. Findings on chest radiographs after prophylactic pulmonary surfactant treatment of premature infants.
Clarke EA; Siegle RL; Gong AK
AJR Am J Roentgenol; 1989 Oct; 153(4):799-802. PubMed ID: 2773736
[TBL] [Abstract][Full Text] [Related]
18. Radiologic observations in severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant.
Mortensson W; Noack G; Curstedt T; Herin P; Robertson B
Acta Radiol; 1987; 28(4):389-94. PubMed ID: 2958051
[TBL] [Abstract][Full Text] [Related]
19. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
20. Endotracheal administration of surfactant in very low birth weight infants with respiratory distress syndrome.
Svenningsen N; Robertson B; Andreason B; Berggren P; Jonson B; Lindroth M
Crit Care Med; 1987 Oct; 15(10):918-22. PubMed ID: 3652706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
